Harbor Capital Advisors’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-96,964
| Closed | -$792K | – | 735 |
|
|
2024
Q1 | $792K | Buy |
96,964
+21,170
| +28% | +$173K | 0.1% | 270 |
|
|
2023
Q4 | $428K | Buy |
75,794
+5,091
| +7% | +$28.8K | 0.08% | 263 |
|
|
2023
Q3 | $132K | Buy |
70,703
+12,056
| +21% | +$22.4K | 0.03% | 399 |
|
|
2023
Q2 | $161K | Buy |
58,647
+5,369
| +10% | +$14.8K | 0.03% | 382 |
|
|
2023
Q1 | $167K | Buy |
53,278
+28,345
| +114% | +$89K | 0.05% | 207 |
|
|
2022
Q4 | $147K | Sell |
24,933
-537
| -2% | -$3.17K | 0.14% | 80 |
|
|
2022
Q3 | $223K | Buy |
25,470
+1,156
| +5% | +$10.1K | 0.2% | 81 |
|
|
2022
Q2 | $183K | Buy |
24,314
+2,446
| +11% | +$18.4K | 0.14% | 84 |
|
|
2022
Q1 | $531K | Sell |
21,868
-5,923
| -21% | -$144K | 0.25% | 76 |
|
|
2021
Q4 | $895K | Buy |
+27,791
| New | +$895K | 0.33% | 77 |
|